OpenLegislation

Paragraph 2

Changes not yet applied. Later legislation changes this provision in ways not yet written into the text below:

Where, at the specific written request of the licensing authority, an application is made for the variation of a marketing authorization so as to—

(a)

restrict any one or more of the indications, dosage or target population, or

(b)

add a contraindication or a warning or both of these,

as a consequence of new information having a bearing on the safe use of the product, the fee payable under regulation 7(1) shall be refunded or, if it has not yet been paid, shall be waived.